Simultaneous spectrophotometric estimation of atorvastatin and fenofibrate in bulk drug and dosage form by using simultaneous equation method

International Journal of ChemTech Research

Volumn 2, Issue 1, 2010, Pages 325-328

  Dhabale, P N ^a   Gharge, D S ^b  

^a Department of Pharmaceutical Analysis   (India)

^b NONE

Author keywords

Atorvastatin; Fenofibrate; Recovery; UV spectrophotometry

Indexed keywords

ATORVASTATIN; FENOFIBRATE; METHANOL;

ACCURACY; ARTICLE; CORRELATION ANALYSIS; DRUG ABSORPTION; DRUG DETERMINATION; DRUG DOSAGE FORM; ECONOMIC ASPECT; TABLET; ULTRAVIOLET SPECTROPHOTOMETRY; VALIDATION PROCESS;

EID: 77953408873     PISSN: None     EISSN: 09744290     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Moffat A.C., Osselton M.D. and Widdop B., Clarke's Analysis of Drugs and Poisons in Pharmaceuticals, body fluids and Postmortem material, 3 rd Edition., Part 2, The Pharmaceutical Press, Great Britain, 2004, 654.
2. Poswar E.L., Radulovic L.L., Cilla D.D., Whitfield L.R. and Sedman A.J., Tolerance and pharmacokinetics of single-dose atorvastatin, a potent inhibitor of HMG-CoA reductase, in healthy subjects, J. Clin. Pharmacol., 1996, 36, 728.
3. Page, Curtis, Sutter, Walkar and Hoffmann, Integrated Pharmacology 2nd , Mosby International Ltd., 2002, 303
4. Altuntas T.G. and Erk N., Liquid chromatographic determination of Atorvastatin in bulk drugs, tablets and human plasma, J. Liq. Chro., 2004, 27 (1), 83.
5. Gowari S.D., Raju M. S. M., Sumanth K.S. and Latha P. V. M., Estimation of Atorvastatin by high performance liquid chromatography in pure and pharmaceutical dosage form, Asian J. Chem, 2005, 17(4), 2571.
6. McKenney J.M., Mccormik L.S., Weis S., Koren M., Kotonek S., and Black D.M., A Randomized Trial of the Effects of Atorvastatin and Niacin in Patients with Combined Hyperlipidemia or Isolated Hypertriglyceridemia, Amer. J. Med., 1998, 104, 137.
7. Black A.E., Sinz M.W., Hayees R.N. and Woolf T.F., metabolism and excretion studies in mouse after single and multiple oral doses of the 3 - hydroxyl-3-methylglutaryl- CoA reductase inhibitor atorvastatin, Drug Metab. Dispos., 1998, 26, 755.
8. Bullen W.W., Miller R.A., Hayes R.N., Development and validation of a high performance liquid chromatography tandem mass spectrometry assay for atorvastatin, orthohydroxy Atorvastatin and para- hydrxy Atorvastatin in human, dog and rat plasma, Amer. Soc. Mass Spectrom., 1999, 10, 55.
9. Yadav S.S., Mhaske D.V., Kakad A.B., Patil B.D., Kadam S.S. and Dhaneshwar S.R., A simple and sensitive HPTLC method for the determination of content uniformity of Atorvastatin calcium tablets, Indian J. Pharm. Sci., 2005, 67(2), 182.
10. Wysocki J., Belowski D., Kalina M., Kochanski L., Okopien B. and Kalina Z., Effects of micronized fenofibrate on insulin resistance in patients with metabolic syndrome, Int. J. Clin. Pharmacol. Ther., 2004, 42 (4), 212-217.